Summary
In serum from patients with DIC at least 3 different FR-antigenic components could
be found. It was difficult to demonstrate these components in the corresponding plasma
samples. It is possible that a portion of these antigens formed as a result of in
vitro clotting despite the presence of proteolytic inhibitors. These results suggest
that the interpretation of “increased split products in serum” may be more complex
than current concepts indicate.